Tiger Eye Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-27,520
Closed -$6.9M 43
2022
Q1
$6.9M Buy
27,520
+9,186
+50% +$2.31M 2.63% 7
2021
Q4
$4.71M Sell
18,334
-6,325
-26% -$1.55M 1.3% 15
2021
Q3
$5.99M Sell
24,659
-44,684
-64% -$10.9M 2.33% 13
2021
Q2
$14.3M Buy
69,343
+6,841
+11% +$1.39M 3.67% 8
2021
Q1
$11.8M Buy
+62,502
New +$11M 2.41% 14
2016
Q2
Sell
-437,479
Closed -$34.1M 42
2016
Q1
$34.1M Buy
+437,479
New +$30.5M 4.28% 6
2015
Q4
Sell
-38,035
Closed -$2.94M 31
2015
Q3
$2.94M Sell
38,035
-89,765
-70% -$7.95M 0.4% 30
2015
Q2
$11.6M Buy
+127,800
New +$10.2M 0.85% 36

Other funds holding HCA

Tiger Eye Capital's HCA Position: Q2 2022 in Review

Tiger Eye Capital sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 27,520 shares — an estimated $6.9M sold.

Tiger Eye Capital first reported a position in HCA in Q2 2015 and held it in 8 quarters. The position peaked at $34.1M in Q1 2016. 884 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

  • Tiger Eye Capital reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
  • Tiger Eye Capital sold 27,520 HCA Healthcare shares in Q2 2022, an estimated $6.9M.
  • Tiger Eye Capital first reported a position in HCA Healthcare in Q2 2015 and held it in 8 quarters.
  • Tiger Eye Capital's HCA Healthcare position peaked at $34.1M in Q1 2016.
  • 884 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Tiger Eye Capital's 13F filing for Q2 2022, filed 15 Aug 2022.